910 related articles for article (PubMed ID: 10200246)
1. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.
Cantley LC; Neel BG
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4240-5. PubMed ID: 10200246
[TBL] [Abstract][Full Text] [Related]
2. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling.
Vazquez F; Sellers WR
Biochim Biophys Acta; 2000 Feb; 1470(1):M21-35. PubMed ID: 10656987
[No Abstract] [Full Text] [Related]
3. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
Ramaswamy S; Nakamura N; Vazquez F; Batt DB; Perera S; Roberts TM; Sellers WR
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2110-5. PubMed ID: 10051603
[TBL] [Abstract][Full Text] [Related]
4. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells.
Li DM; Sun H
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15406-11. PubMed ID: 9860981
[TBL] [Abstract][Full Text] [Related]
5. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
[TBL] [Abstract][Full Text] [Related]
6. A surprising function for the PTEN tumor suppressor.
Hopkin K
Science; 1998 Nov; 282(5391):1027,1029-30. PubMed ID: 9841444
[No Abstract] [Full Text] [Related]
7. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.
Wu X; Senechal K; Neshat MS; Whang YE; Sawyers CL
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15587-91. PubMed ID: 9861013
[TBL] [Abstract][Full Text] [Related]
8. [PTEN expression in endometrial cancer and the prognosis].
Kanamori Y; Uegaki K; Kigawa J; Terakawa N
Nihon Rinsho; 2004 Oct; 62 Suppl 10():406-9. PubMed ID: 15535277
[No Abstract] [Full Text] [Related]
9. The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway.
Arico S; Petiot A; Bauvy C; Dubbelhuis PF; Meijer AJ; Codogno P; Ogier-Denis E
J Biol Chem; 2001 Sep; 276(38):35243-6. PubMed ID: 11477064
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.
Haas-Kogan D; Shalev N; Wong M; Mills G; Yount G; Stokoe D
Curr Biol; 1998 Oct; 8(21):1195-8. PubMed ID: 9799739
[TBL] [Abstract][Full Text] [Related]
11. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
[TBL] [Abstract][Full Text] [Related]
12. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.
Asano T; Yao Y; Zhu J; Li D; Abbruzzese JL; Reddy SA
Oncogene; 2004 Nov; 23(53):8571-80. PubMed ID: 15467756
[TBL] [Abstract][Full Text] [Related]
13. Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults.
Zhou XP; Marsh DJ; Morrison CD; Chaudhury AR; Maxwell M; Reifenberger G; Eng C
Am J Hum Genet; 2003 Nov; 73(5):1191-8. PubMed ID: 14566704
[TBL] [Abstract][Full Text] [Related]
14. PTEN expression causes feedback upregulation of insulin receptor substrate 2.
Simpson L; Li J; Liaw D; Hennessy I; Oliner J; Christians F; Parsons R
Mol Cell Biol; 2001 Jun; 21(12):3947-58. PubMed ID: 11359902
[TBL] [Abstract][Full Text] [Related]
15. PTEN: from pathology to biology.
Sulis ML; Parsons R
Trends Cell Biol; 2003 Sep; 13(9):478-83. PubMed ID: 12946627
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors.
Xu G; Zhang W; Bertram P; Zheng XF; McLeod H
Int J Oncol; 2004 Apr; 24(4):893-900. PubMed ID: 15010827
[TBL] [Abstract][Full Text] [Related]
17. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
Pianetti S; Arsura M; Romieu-Mourez R; Coffey RJ; Sonenshein GE
Oncogene; 2001 Mar; 20(11):1287-99. PubMed ID: 11313873
[TBL] [Abstract][Full Text] [Related]
18. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
[TBL] [Abstract][Full Text] [Related]
19. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.
Sun H; Lesche R; Li DM; Liliental J; Zhang H; Gao J; Gavrilova N; Mueller B; Liu X; Wu H
Proc Natl Acad Sci U S A; 1999 May; 96(11):6199-204. PubMed ID: 10339565
[TBL] [Abstract][Full Text] [Related]
20. Loss of PTEN expression leading to high Akt activation in human multiple myelomas.
Hyun T; Yam A; Pece S; Xie X; Zhang J; Miki T; Gutkind JS; Li W
Blood; 2000 Nov; 96(10):3560-8. PubMed ID: 11071655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
